Aimei Health Technology (NASDAQ:AFJK) Stock Price Down 0.5% – Should You Sell?

Shares of Aimei Health Technology Co., Ltd (NASDAQ:AFJK) traded down 0.5% on Thursday . The stock traded as low as $11.00 and last traded at $10.96. 301 shares were traded during mid-day trading, a decline of 99% from the average session volume of 33,230 shares. The stock had previously closed at $11.01.

Aimei Health Technology Stock Performance

The business has a fifty day moving average of $10.87 and a 200 day moving average of $10.67.

Hedge Funds Weigh In On Aimei Health Technology

A number of hedge funds and other institutional investors have recently made changes to their positions in AFJK. Virtu Financial LLC bought a new position in shares of Aimei Health Technology during the third quarter valued at approximately $123,000. Harraden Circle Investments LLC bought a new position in shares of Aimei Health Technology during the fourth quarter valued at approximately $1,117,000. Quarry LP bought a new position in shares of Aimei Health Technology during the fourth quarter valued at approximately $1,605,000. Rivernorth Capital Management LLC raised its holdings in shares of Aimei Health Technology by 9.1% during the third quarter. Rivernorth Capital Management LLC now owns 172,789 shares of the company’s stock valued at $1,811,000 after acquiring an additional 14,391 shares in the last quarter. Finally, Centiva Capital LP raised its holdings in shares of Aimei Health Technology by 1.4% during the fourth quarter. Centiva Capital LP now owns 232,693 shares of the company’s stock valued at $2,460,000 after acquiring an additional 3,100 shares in the last quarter. Institutional investors own 45.58% of the company’s stock.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.